SCHEMBL2726294

SCHEMBL2726294

Fc1ccc2c(-c3ccc(F)c(F)c3)c3c(F)c(F)c(F)c(F)c3c(-c3ccccc3)c2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.35
HPGD P15428 2/20 0.35
MAP2 P11137 1/20 0.35
MAP2K4 P45985 1/20 0.35
PTGS2 P35354 2/20 0.34
GRM5 P41594 2/20 0.34
TOP1 P11387 2/20 0.34
TAAR1 Q96RJ0 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
PARP1 P09874 1/20 0.33
PARP3 Q9Y6F1 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
CCNE2 O96020 1/20 0.33
CDK4 P11802 1/20 0.33
CCND1 P24385 1/20 0.33
CCNE1 P24864 1/20 0.33
CDK2 P24941 1/20 0.33
CAMK2B Q13554 1/20 0.33
CAMK2G Q13555 1/20 0.33
CAMK2D Q13557 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12086190 1.00 LMNA (0.35) LMNAHPGDMAP2MAP2K4PTGS2
SCHEMBL2726046 0.92 PARP1 (0.36) GRM5PARP1PARP3CCNE2CDK4
SCHEMBL12086207 0.91 LMNA (0.37) LMNAHPGDMAP2MAP2K4PTGS2
SCHEMBL2727051 0.91 LMNA (0.37) LMNAHPGDMAP2MAP2K4PTGS2
SCHEMBL2726814 0.89 TOP1 (0.35) MAP2TOP1DHODHMAOB
SCHEMBL2725679 0.88 PARP1 (0.34) GRM5PARP1PARP3CCNE2CDK4
SCHEMBL2710027 0.88 PARP1 (0.34) GRM5PARP1PARP3
SCHEMBL2726789 0.88 LMNA (0.40) LMNAHPGDMAP2MAP2K4PTGS2
SCHEMBL2709829 0.88 ACHE (0.41) LMNAHPGDMAP2MAP2K4PTGS2
SCHEMBL12086186 0.88 LMNA (0.39) LMNAHPGDMAP2MAP2K4PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
US-8257620-B2 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. (US) 2012-09-04 US disclosed
EP-2445987-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS Cyalume Technologies, Inc (US) 2012-05-02 EP disclosed
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. 2010-12-30 US disclosed
WO-2010151654-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECHNOLOGIES, INC. (US) 2010-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYP2F1, FLAD1, AFF1 LMNA 1569/4885HPGD 381/4885MAP2 886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.